Article Text
Abstract
Background The p16INK4A protein (p16) is a cyclin-dependent kinase inhibitor that arrests the cell cycle in the G1 phase.
Aim To explore the potential of p16 as a predictive marker for lymph node (LN) metastasis and prognosis in cervical carcinomas.
Methods 145 patients diagnosed with FIGO stage I to IV cervical carcinoma were studied; 95 underwent LN dissection. The expression of p16 protein was studied by immunohistochemistry using tissue microarrays.
Results Overexpression of p16 was seen in 108 of 145 (74.5%) invasive carcinomas. There was a significant correlation between p16 expression and LN metastasis (p=0.007). Patients with p16 overexpression had poorer survival than patients with p16 underexpression (59.3% vs 83.8% 5-year survival rate, log-rank p=0.015). In univariate analysis, p16 expression was a significant predictor of survival (RR 2.76, p=0.02).
Conclusions Results suggest that p16 expression is an important predictive factor of LN metastasis in cervical cancer patients. Moreover, p16 overexpression is associated with a poor prognosis. Therefore, immunohistochemical evaluation of p16 expression is of potential value for treatment planning in cervical carcinomas.
- p16INK4A
- lymph node metastasis
- cervical carcinoma
- prognosis
- immunohistochemistry
- HPV
- oncology
- tumour markers
Statistics from Altmetric.com
Footnotes
Funding This study was supported by research grants (SKH-8302-98-DR-23, SKH-8302-99-DR-29) from the Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
Competing interests None.
Patient consent Obtained.
Ethics approval Ethics approval was provided by the Institutional Review Board of Shin Kong Wu Ho-Su Memorial Hospital.
Provenance and peer review Not commissioned; externally peer reviewed.